Actinium Pharmaceuticals, Inc. SEC filings ATNM

Actinium Pharmaceuticals, Inc. has 511 filings in SEC EDGAR's recent list, going back to Feb 5, 2007. Its latest annual report, Form ARS, was filed on Oct 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Oct 15, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Nov 5, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 6, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2024 Dec 31, 2023
ARS Annual report to shareholders Nov 9, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K/A Amended annual report Jul 13, 2020 Dec 31, 2019
10-K/A Amended annual report Jun 16, 2020 Dec 31, 2019
10-K Annual report May 8, 2020 Dec 31, 2019
10-K Annual report Mar 15, 2019 Dec 31, 2018
10-K Annual report Mar 16, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K Annual report Mar 11, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
ARS Annual report to shareholders Dec 18, 2014 Dec 31, 2013
10-K/A Amended annual report Apr 10, 2014 Dec 31, 2013
10-K Annual report Feb 28, 2014 Dec 31, 2013
10-K Annual report Mar 29, 2013 Dec 31, 2012
10-K Annual report Apr 12, 2012 Dec 31, 2011
10-K Annual report Mar 3, 2011 Dec 31, 2010
10-K Annual report Mar 16, 2010 Dec 31, 2009
10-K/A Amended annual report Dec 29, 2009 Dec 31, 2008
10-K Annual report Feb 20, 2009 Dec 31, 2008

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ATNM (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1388320
Former names
Cactus Ventures, Inc. (until Mar 29, 2013)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.